Bezafibrate
Brand names: BEZALIP
Therapeutic Indications
Bezafibrate is indicated for:
at least one of
Pure hypercholesterolaemia
Pure hyperglyceridaemia
Mixed hyperlipidaemia
Hyperchylomicronaemia
Other hyperlipidaemia
Hyperlipidaemia, unspecified
Pure hyperglyceridaemia
Mixed hyperlipidaemia
Hyperchylomicronaemia
Other hyperlipidaemia
Hyperlipidaemia, unspecified
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral
Contraindications
Active ingredient Bezafibrate is contraindicated in the following cases:
No gender/age discrimination
at least one of
Unspecified adverse effect of drug or medicament
Lactation
Hepatic insufficiency
Pregnancy
Renal failure
Primary biliary cirrhosis
Nephrotic syndrome
MAO inhibitors
MAO inhibitors and diuretics
Perhexiline
Dependence on renal dialysis
Cholelithiasis
Cholecystitis
Lactation
Hepatic insufficiency
Pregnancy
Renal failure
Primary biliary cirrhosis
Nephrotic syndrome
MAO inhibitors
MAO inhibitors and diuretics
Perhexiline
Dependence on renal dialysis
Cholelithiasis
Cholecystitis